Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550938 · ClinicalTrials.gov registry record · NA
Primer Aligner Study
A NA study, sponsored by Align Technology.
- Completed
- Registry status
- NA
- Development phase
- 253
- Enrollment target
NCT02550938: Completed NA study, sponsored by Align Technology.
NCT02550938 is a NA study that has completed, run by Align Technology. The registered enrollment target is 253 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02550938, a NA study, has completed, sponsored by Align Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 253 participants
- Enrollment target
Study Summary
To demonstrate that a primer aligner product can achieve similar results to the currently marketed product.
Primary Outcome
Total treatment time was measured in days. The less days a subject was in treatment, the better.
Interventions
- DEVICE Invisalign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2015-05 |
| Est. Completion | 2020-09 |
| Phase | NA |
What the finished NCT02550938 record still lists
NCT02550938 is an interventional study that assigns participants to a tested intervention. The registered 253 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Invisalign is the first listed.
NCT02550938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02550938 about?
NCT02550938 is a clinical study titled "Primer Aligner Study". To demonstrate that a primer aligner product can achieve similar results to the currently marketed product.
What is the current status of trial NCT02550938?
This trial is currently completed. It is a NA study. The enrollment target is 253 participants. The study started on 2015-05. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02550938?
The interventions under investigation include: Invisalign (DEVICE).
Who is sponsoring clinical trial NCT02550938?
This trial is sponsored by Align Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02550938's enrollment target sits among peer trials
253 407th of 2000 higher than 1,594 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia